Inhaled dry powder insulin for the treatment of diabetes mellitus
-
Add time:09/04/2019 Source:sciencedirect.com
Background:Inhaled dry powder insulin (IDPI) is the first inhaled insulin approved for the treatment of type 1 and type 2 diabetes mellitus (DM).
We also recommend Trading Suppliers and Manufacturers of INSULIN LISPRO (5.97 MG) (cas 133107-64-9). Pls Click Website Link as below: cas 133107-64-9 suppliers
Prev:Establishment of the First National Reference Standard for Insulin Lispro: Report of a collaborative study
Next:Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Developing a Pulmonary Insulin Delivery System for Patients with Diabetes09/07/2019
- Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A1chieve study09/06/2019
- Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/7009/05/2019
- Establishment of the First National Reference Standard for Insulin Lispro: Report of a collaborative study09/03/2019
-
Health and Chemical more >